Article List

WPRIM Management System> DCMS> Chinese Journal of Lung Cancer> 2010> 13> 6

Volume: 13 Issue: 6

1. A case report and literature review of small intestinal metastasis of large cell lung cancer.	Page:655—658
2. Diagnostic significance of combining telomerase activity with CYFRA21-1 level in differentiating malignant pleural effusion caused by lung cancer from benign pleural effusion.	Page:652—654
3. The location and molecular regulating mechanism of tracheal and lung stem cells.	Page:648—651
4. Research progress on the relationship between insulin-like growth factor-I and lung cancer.	Page:642—647
5. Current status and prospects of maintenance therapy in advanced stage non-small cell lung cancer.	Page:637—641
6. Physicians' role in advancing tobacco control in China.	Page:632—636
7. Diagnosis and treatment of tracheal or bronchuotracheal adenoid cystic carcinoma.	Page:628—631
8. The clinical value of routine preoperative surgical staging to mediastinal lymph nodes on lung cancer.	Page:624—627
9. Meta-analysis of the relationship between passive smoking population in China and lung cancer.	Page:617—623
10. Expression of transient receptor potential canonical channel proteins in human non-small cell lung cancer.	Page:612—616
11. Study on solitary pulmonary nodules: correlation between diameter and clinical manifestation and pathological features.	Page:607—611
12. K-RAS gene mutations in patients with non-small cell lung cancer.	Page:602—606
13. Expression and its relationship of PRL-3 and RhoC in non-small cell lung cancer.	Page:598—601
14. Retrospective study of clinicopathological characteristics in bronchopulmonary carcinoid.	Page:591—597
15. The correlation between the expression of Wnt1 and prognosis in resected non-small cell lung cancer.	Page:586—590
16. Effects of recombinant human endostatin and docetaxel on MMP and its following anti-neoplastic effect under different administration sequences.	Page:580—585
17. Study on the iodine 125 uptake of H460 lung cancer cell line by co-transfection with the human sodium/iodide symporter and the human thyroperoxidase.	Page:575—579
18. Establishment and its biological characteristics of patient-derived lung cancer xenograft models.	Page:568—574
19. Adverse events related to bevacizumab and the management principles in non-small cell lung cancer.	Page:563—567